Detection of circulating tumor DNA for advanced bladder cancer: where are we going?
作者信息
Morales-Barrera Rafael, González Macarena, Suárez Cristina, Carles Joan
机构信息
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
Hospital of Mataró, Barcelona, Spain.
出版信息
Transl Androl Urol. 2018 Mar;7(Suppl 1):S101-S103. doi: 10.21037/tau.2018.01.01.
Abstract
摘要
相似文献
1
Detection of circulating tumor DNA for advanced bladder cancer: where are we going?晚期膀胱癌循环肿瘤DNA的检测：我们何去何从？
Transl Androl Urol. 2018 Mar;7(Suppl 1):S101-S103. doi: 10.21037/tau.2018.01.01.
2
Circulating Biomarkers in Bladder Cancer.膀胱癌中的循环生物标志物
Bladder Cancer. 2016 Oct 27;2(4):369-379. doi: 10.3233/BLC-160075.
3
Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients.细胞角蛋白-20逆转录聚合酶链反应作为检测膀胱癌患者外周血和骨髓中循环肿瘤细胞的新工具。
Eur Urol. 2001 May;39(5):507-15; discussion 516-7. doi: 10.1159/000052496.
4
Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival.晚期膀胱尿路上皮癌患者循环肿瘤细胞：与肿瘤分期、淋巴结转移、FDG-PET检查结果及生存率的相关性
Urol Oncol. 2017 Oct;35(10):606.e9-606.e16. doi: 10.1016/j.urolonc.2017.05.021. Epub 2017 Jul 1.
5
Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer.循环肿瘤细胞作为膀胱癌潜在的生物标志物
J Urol. 2015 Sep;194(3):790-8. doi: 10.1016/j.juro.2015.02.2951. Epub 2015 Apr 23.
6
The role of circulating tumour cells and nucleic acids in blood for the detection of bladder cancer: A systematic review.循环肿瘤细胞和血液中的核酸在膀胱癌检测中的作用：系统评价。
Cancer Treat Rev. 2018 May;66:56-63. doi: 10.1016/j.ctrv.2018.03.007. Epub 2018 Apr 17.
7
Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling.利用深度较浅的全基因组胞外游离尿 DNA 亚硫酸氢盐测序技术，对甲基化和拷贝数进行分析，无创性检测膀胱癌。
Clin Chem. 2019 Jul;65(7):927-936. doi: 10.1373/clinchem.2018.301341. Epub 2019 Apr 15.
8
Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel.通过肿瘤抑制基因高甲基化检测板检测尿液中的膀胱癌
Clin Cancer Res. 2004 Mar 15;10(6):1887-93. doi: 10.1158/1078-0432.ccr-03-0127.
9
Advanced bladder cancer...where are we now and where are we going?
World J Urol. 2002 Aug;20(3):143. doi: 10.1007/s00345-002-0274-3. Epub 2002 Jun 7.
10
Going with the flow: from circulating tumor cells to DNA.随波逐流：从循环肿瘤细胞到 DNA。
Sci Transl Med. 2013 Oct 16;5(207):207ps14. doi: 10.1126/scitranslmed.3006305.
本文引用的文献
1
Clinical Significance of Histologic Variants of Bladder Cancer.膀胱癌组织学变异型的临床意义。
J Natl Compr Canc Netw. 2017 Oct;15(10):1268-1274. doi: 10.6004/jnccn.2017.7027.
2
Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer.免疫肿瘤状态可能预测膀胱癌新辅助化疗的反应和根治性膀胱切除术后的结局。
Sci Rep. 2017 Oct 4;7(1):12682. doi: 10.1038/s41598-017-12892-5.
3
Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis.通过液体活检分析监测晚期膀胱癌的治疗反应和转移复发。
Eur Urol. 2018 Apr;73(4):535-540. doi: 10.1016/j.eururo.2017.09.011. Epub 2017 Sep 27.
4
Bladder cancer.膀胱癌。
Nat Rev Dis Primers. 2017 Apr 13;3:17022. doi: 10.1038/nrdp.2017.22.
5
Liquid biopsies come of age: towards implementation of circulating tumour DNA.液体活检时代的到来：迈向循环肿瘤 DNA 的临床应用。
Nat Rev Cancer. 2017 Apr;17(4):223-238. doi: 10.1038/nrc.2017.7. Epub 2017 Feb 24.
6
Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer.膀胱癌疾病监测中的液体活检分析 FGFR3 和 PIK3CA 热点突变
Eur Urol. 2017 Jun;71(6):961-969. doi: 10.1016/j.eururo.2016.12.016. Epub 2017 Jan 6.
7
Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer.高危膀胱癌患者癌症基因组的靶向外显子组测序。
Eur Urol. 2016 Nov;70(5):714-717. doi: 10.1016/j.eururo.2016.07.049. Epub 2016 Aug 9.
8
Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma.化疗反应生物标志物ERCC2在肌层浸润性尿路上皮膀胱癌中的临床验证
JAMA Oncol. 2016 Aug 1;2(8):1094-6. doi: 10.1001/jamaoncol.2016.1056.
9
Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer.膀胱癌患者液体活检中的基因组改变。
Eur Urol. 2016 Jul;70(1):75-82. doi: 10.1016/j.eururo.2016.01.007. Epub 2016 Jan 20.
10
Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer.DNA修复基因缺陷可预测肌层浸润性膀胱癌对基于顺铂的新辅助化疗的反应。
Eur Urol. 2015 Dec;68(6):959-67. doi: 10.1016/j.eururo.2015.07.009. Epub 2015 Aug 1.
Zotero 插件